Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study-Reference-Cited by-同舟云学术

Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study

Published:2019-10-08 Issue:1 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Le Teuff Gwénaël¹²^ORCID,Castaneda‐Heredia Alicia³,Dufour Christelle³^ORCID,Jaspan Timothy⁴,Calmon Raphael⁵,Devos Annick⁶,McHugh Kieran⁷,Leblond Pierre⁸,Frappaz Didier⁹,Aerts Isabelle¹⁰^ORCID,Zwaan Christian M.⁶^ORCID,Ducassou Stéphane¹¹^ORCID,Chastagner Pascal¹²,Verschuur Arnauld¹³,Corradini Nadège¹⁴,Casanova Michela¹⁵,Rubie Hervé¹⁶,Riccardi Riccardo¹⁷,Le Deley Marie‐Cecile¹²,Vassal Gilles¹⁸,Geoerger Birgit³¹⁹^ORCID,

Affiliation:

1. Université Paris‐Saclay, Univ Paris‐Sud, UVSQ, CESP, INSERM Villejuif France

2. Gustave Roussy Cancer CenterUniversité Paris‐SaclayBiostatistics and Epidemiology Unit Villejuif France

3. Gustave Roussy Cancer CenterDepartment of Pediatric and Adolescent Oncology Villejuif France

4. University Hospital Nottingham Nottingham United Kingdom

5. Necker Enfants Malades Paris France

6. Erasmus MC/Sophia Children's Hospital Rotterdam Rotterdam The Netherlands

7. Great Ormond Street Hospital for Children London United Kingdom

8. Centre Oscar‐LambretDepartment of Pediatric Oncology Lille France

9. Institut d'Hématologie et d'Oncologie pédiatrique Lyon France

10. Institut CurieSIREDO Oncology CenterPSL Research University Paris France

11. Centre Hospitalier Pellegrin Hôpital des Enfants Bordeaux France